Sarfaraz K. Niazi (full name: Sarfaraz Khan Niazi; Urdu: سرفراز خان نیازی, Hindi: सर्फ़राज़ ख़ान नियाज़ी) was born in Lucknow, India in 1949; he migrated to Karachi, Pakistan in 1962, and to the United States in 1970. He has published 100+ scholarly papers, owns 40+ patents, delivered 300+ talks on scientific and literary topics, written over 30+ technical and literary books (including a collection of his own poems). His textbooks are required reading worldwide, and he allows their distribution royalty-free in developing countries, which allows companies and governments in developing countries to manufacture safe and effective drugs and vaccines at an affordable cost. He also teaches scientists in developing countries on creating value through intellectual property and, in this capacity, serves as an advisor to the Government of Pakistan. He is widely recognized for his translations of ghazals (love poems) of one of the most widely read poets, Ghalib. He broadcasts explications of Ghalib’s poetry on the Voice of America every Sunday.
Contents |
Sarfaraz K. Niazi was born in Lucknow, Uttar Pradesh, India on July 10, 1949, to Niaz Fatehpuri and Gulzar Begum. Niaz Fatehpuri was a renowned poet, philosopher, author, polemicist, and intellectual, who made a mark in the worlds of religion and literature in Pakistan and India. Sarfaraz migrated to Karachi, Sindh, Pakistan with his father in 1962. Niaz Fatehpuri died in 1966 in Karachi, Sindh, Pakistan, when Sarfaraz was 17 years old.
In 1974, he married Anjum Iqbal (now Anjum Niazi), the daughter of Abdul Rahim Khan[1] and Iqbal Bano.[2] Sarfaraz and Anjum are the parents of two sons, Omayr K. Niazi[3] and Ali K. Niazi,[4] and one daughter, Nabiha K. Niazi-Ahmed.[5]
Sarfaraz obtained his bachelor of science degree in chemistry in 1966 from the University of Karachi in Karachi, Pakistan. Then he obtained a Marketing Certificate in 1967 from the Institute of Business Administration when it was a part of the University of Karachi. In 1969, he obtained his bachelor of science degree in pharmacy from the University of Karachi, and then relocated in 1970 to the United States. He obtained his master of science degree in pharmaceutical sciences in 1971 from Washington State University in Pullman, WA, and then moved to Illinois. In 1974, he obtained his doctorate in pharmaceutical sciences from the University of Illinois Medical Center, affiliated with the University of Illinois at Chicago.
From 1974 to 1988, he taught at the College of Pharmacy at the University of Illinois at Chicago. In 1988, he began working for Abbott Laboratories as its Director of Technical Affairs in Karachi, Pakistan. At the same time, he was Professor of Pharmacology at the Aga Khan University Hospital in Karachi, Pakistan. In 1996, he began working for Gulf Pharmaceutical Industries (also known as Julphar) in Ras al-Khaimah of the United Arab Emirates. From 1996 to 1999, he worked in the United Arab Emirates, and from 1999 to 2008, he managed the company's US headquarters in Deerfield, IL. In 1997, he established his own consulting business, known as Pharmaceutical Scientist, Inc., and in 2003 established Therapeutic Proteins, Inc., in Chicago, IL, doing work on such biopharmaceuticals as filgrastim, erythropoietin, interferon, PEGylation, and monoclonal antibodies, to create biogeneric versions of these products.
Since 2004, he has served as an adjunct professor at the University of Houston College of Pharmacy, and since 2007 as an adjunct professor at the HEJ Research Institute of Chemistry at the University of Karachi.
Mirza Asadullah Baig Khan (1797 to 1869), better known as Ghalib, was “one of the most popular an influential poets of the Urdu language”[6] and “is the best known and the most widely read Indo-Persian poet of his time.”[7] His poetry, consisting of ghazals or love poems, are widely recited, and have been sung by some of South Asia’s most prominent singers. Indeed, his poetry is used in every-day discourse by many South Asians. He wrote his ghazals in Urdu (the lingua franca of the various peoples of the Mughal Empire and the British Raj) and in Farsi (the language of the Mughal Court and of the Muslim learned classes). While many have translated portions of Ghalib’s divan (collection of poetry) into English, in 2002 his entire Urdu divan was translated for the first time by Sarfaraz K. Niazi.[8][9][10] One reviewer commented that "what Fitzgerald is to Khayaam, Niazi is to Ghalib," referring to Edward FitzGerald's translation of Omar Khayyam's Rubaiyat.[11]
In addition to studying classic poets like Ghalib, Sarfaraz has written his own poetry, of which there are around 200 ghazals.
One of his early poems, which won the attention of Zulfiqar Ali Bukhari during a mushaira by Radio Pakistan for young poets when Sarfaraz was 13 years old, was:
دلِ بیتاب کسی طرح بہلتا ہی نہیں
شاید اِس دردِ محبت کا مداوا ہی نہیں
The tumultuous heart does not settle down no matter what
Perhaps there is no resolve to this pain of love.
حالِ دل کہنے سے خود داری نے روکا ہمکو
اُس سے پوچها تو بہت ہم نے بتایا ہی نہیں
Self-pride kept from telling the condition of my heart
She did keep asking but we just couldn’t tell.
پوچهتے کیا ہو تم اب حالِ نیازی ہم سے
در پہ اُسکے جو وه بیٹها تو پهر اُٹهّا ہی نہیں
Why are you asking the condition of Niazi from me;
Once he sat down at her doorsill, he just couldn’t get up.— Sarfaraz K. Niazi, Sarfaraz Niazi's Poetry page
Sarfaraz develops his talents as a photographer as well, experimenting with bokeh or artistic blurring and 3D fadeout. His uses a Leica M9 with a Noctilux 0.95 50mm lens.
Below is an example of one of his photographs:
Sarfaraz K. Niazi has been involved in inventing and patenting his inventions for decades. A partial list of items he has worked on is:
When published, this was the first textbook in the developing discipline of clinical pharmacokinetics. The book was written for the classroom for a one-semester course, and was quickly accepted by pharmacy schools worldwide, and is still used as a textbook, having gone through dozens of reprints.
This was the first book on the connection between heart disease and Omega-3 fats. The book described in detail the reasons for this, and made many recommendations for consumers and healthcare professionals. One of the most significant discussions was regarding trans fats. Petitions were filed with the US FDA but it was not until 20 years later that the US FDA required the posting of trans fats on nutrition facts label, which was proposed in this book. The book was also a Book of the Month at Rodale, Inc., and many manufacturers bundled the book with fish oil product sales.
What started as a syndicated column in Dawn wherein Sarfaraz wrote three health tips a day, touching especially on misconceptions in healthcare, was published as an illustrated book with cartoons and images. As this was a short book that was easy to read and understand, it became a bestseller by Ferozsons.
This is the first English translation of Ghalib’s complete Urdu divan. Upon publication, this book became an instant worldwide success with over ten printings and several hundred thousand copies sold. This book contains the divan of Ghalib in Urdu, Romanized transliteration, English translation, explications, paintings by Sadequain to depict verses, and a comprehensive dictionary of the words used by Ghalib.
This is the same book as the one published by Rupa & Co., except that this a deluxe large edition and includes color plates of Sadequain’s paintings of Ghalib’s verses. Like the edition published by Rupa & Co., this was bestseller and has gone through several reprints.
When Sarfaraz became a patent agent in 2002, he realized that the USPTO was transitioning to electronic filing of patents. This realization was not of great interest to patent attorneys, who were well-established with paper a applications. Furthermore, the USPTO’s electronic system was not user-friendly. Therefore, Sarfaraz published this book to help explain the USPTO’s electronic filing process and software, the first book to provide step-by-step explanations on filing patents electronically in the US and in Europe.
This is the largest book written on the topic and the first of its kind ever published. The book contains methods of manufacturing injectable and other sterile drugs, such as eye drops and ear drops, and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the largest book written on the topic and the first of its kind ever published. The book contains methods of manufacturing tablets and capsules, and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the largest book written on the topic and the first of its kind ever published. The book contains methods of manufacturing powders and capsules, and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the largest book written on the topic and the first of its kind ever published. The book contains methods of manufacturing injectable and other sterile liquids, syrups and solutions, and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the largest book written on the topic and the first of its kind ever published. The book contains methods of manufacturing ointments, creams, suppositories, etc., and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the largest book written on the topic and the first of its kind ever published. The book contains methods of manufacturing over the counter (OTC) drugs of all types, and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the second edition of the same book published in 2004; there was a tremendous demand for this book and the new edition updates formulations, includes newer regulatory guidelines from the US FDA and the EMEA and includes list of approved excipients as well as other ready reference materials to allow manufacturers to formulate and manufacture these drugs at the lowest possible cost. The book contains methods of manufacturing tablets and capsules and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the second edition of the same book published in 2004; there was a tremendous demand for this book and the new edition updates formulations, includes newer regulatory guidelines from the FDA and the EMEA and includes list of approved excipients as well as other ready reference materials to allow manufacturers to formulate and manufacture these drugs at the lowest possible cost. The book contains methods of manufacturing powders and and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the second edition of the same book published in 2004; there was a tremendous demand for this book and the new edition updates formulations, includes newer regulatory guidelines from the FDA and the EMEA and includes list of approved excipients as well as other ready reference materials to allow manufacturers to formulate and manufacture these drugs at the lowest possible cost. The book contains methods of manufacturing syrups, liquids and similar products and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the second edition of the same book published in 2004; there was a tremendous demand for this book and the new edition updates formulations, includes newer regulatory guidelines from the FDA and the EMEA and includes list of approved excipients as well as other ready reference materials to allow manufacturers to formulate and manufacture these drugs at the lowest possible cost. The book contains methods of manufacturing ointments, creams, suppositories and other soft products and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish a FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the second edition of the same book published in 2004; there was a tremendous demand for this book and the new edition updates formulations, includes newer regulatory guidelines from the FDA and the EMEA and includes list of approved excipients as well as other ready reference materials to allow manufacturers to formulate and manufacture these drugs at the lowest possible cost. This is the largest book written on the topic and the first of its kind ever published. The book contains methods of manufacturing all types of over the counter (OTC) drugs and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the second edition of the same book published in 2004; there was a tremendous demand for this book and the new edition updates formulations, includes newer regulatory guidelines from the FDA and the EMEA and includes list of approved excipients as well as other ready reference materials to allow manufacturers to formulate and manufacture these drugs at the lowest possible cost. The book contains methods of manufacturing injectable and other sterile drugs like eye drops, eardrops, etc., and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This is the second edition of the same book published in 2004; there was a tremendous demand for this book and the new edition updates formulations, includes newer regulatory guidelines from the FDA and the EMEA and includes list of approved excipients as well as other ready reference materials to allow manufacturers to formulate and manufacture these drugs at the lowest possible cost. The book contains methods of manufacturing all dosage formulations used in the pharmaceutical industry and includes actual formulations that are fully scalable and adoptable by the industry without any trial and error. Hundreds of drugs and their formulations are provided in the book. The book also provides in the first section full details of regulatory compliance and makes hands on recommendations on how to establish an FDA-approvable manufacturing facility. The book also talks about the personal experience of the author in formulating and manufacturing these dosage forms.
This chapter in one of the bestselling books on drug development provides a detailed mathematical modeling of the systems used to develop new drugs and new formulations. With increased requirements of providing safety and efficacy data for new drugs, pharmacokinetic and pharmacodynamics studies have become routine exercises; however, a smart use of these mathematical models cuts down the cost of drug development substantially.
This is the first handbook describing a hands-on approach to developing drugs from substantial drug leads, preformulation discipline characterizes the nature of drug, its potential for absorption in the human body using various routes of administration, and drug delivery systems. The book describes in detail all required parameters to characterize new chemical entities and, for the first time, includes botanical drugs as well. This book serves as a teaching manual for new scientists entering the field of drug development, and is in use by large and small pharmaceutical companies.
Bioequivalence testing is a fundamental requirement for developing generic drugs. This book is a manual of establishing bioequivalence testing, and includes actual reports submitted to the US FDA that resulted in the approval of the drugs. Detailed chapters describe the various pitfalls in organizing and conducting these studies as well as provide a detailed scientific basis of the factors that can affect the bioequivalence of drugs. The book allows the industry to design easily approvable study protocols and save millions of dollars.
This is modified reprint of the textbook published in 1979. The book continues to be used by hundreds of schools of pharmacy, medicine, and nursing in India, so a paperback edition of the book allows these institutions (in India and worldwide) to afford to provide this timeless teaching tool for students unable to pay the high price of US editions of textbooks.
The art book version of Love Sonnets of Ghalib is a totally revised edition of the original, and includes translations as well as art from a prominent artist.
This is an extension of the book Wine of Passion but with additional scripts (such as Hindi and Romanized transliteration). When published, this will be the largest book of Ghalib’s love poems.
his is the first book on the subject of the use of disposable or single-use components in the biological drug manufacturing industry. Disposables are fast expanding and finding use in bioprocessing, and this book discusses all aspects, from the scientific rationale of using them to regulatory problems in their acceptance to their environmental impact. This book recognizes all major suppliers and offers suggestions to the industry on adopting these systems to comply with the future compliance requirements of the FDA and the EMEA.
This will be the first complete translation of Ghalib's Persian divan of ghazals. This will also be the first time his Persian divan will be available in nastaliq, and will be just as historical for Ghalib's Persian divan as was Sarfaraz's English translation of Ghalib's complete Urdu divan.
This book is a compilation of a lifetime of writing on the subject of reality. Based on anthropologic principles, the book describes with lucidity the reality of humanity and its place in the universe. The book has three parts: the first part is “Universe Beyond,” which talks about the universe that we can barely see yet we can conjecture about its beginning and end; the second part is “Universe Around” that talks about our interactions with others as humans as well as with nature, our behavior and our survival instincts as well as our genetic programming that makes us subservient to Nature; and the third part is “Universe Within,” which talks about who we are and how we are constructed, explaining phenomenon from déjà vu to the immune response to organ regrowth from stem cells. This book is a complete thesis on understanding everything about what makes the Universe and us a part of this Creation.
In 2002, he became a patent agent with the United States Patent and Trademark Office. As a licensed patent agent, he teaches courses on creativity and inventiveness on behalf of the Higher Education Commission of Pakistan. He has helped scientists and inventors around the world (especially in developing countries) secure patents from the USPTO for their inventions.